117 related articles for article (PubMed ID: 2403598)
1. Infrequent ras oncogene point mutations in renal cell carcinoma.
Nanus DM; Mentle IR; Motzer RJ; Bander NH; Albino AP
J Urol; 1990 Jan; 143(1):175-8. PubMed ID: 2403598
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the ras protooncogenes are rare events in renal cell cancer.
Rochlitz CF; Peter S; Willroth G; de Kant E; Lobeck H; Huhn D; Herrmann R
Eur J Cancer; 1992; 28(2-3):333-6. PubMed ID: 1591047
[TBL] [Abstract][Full Text] [Related]
3. Absence of ras family point mutations at codons 12, 13 and 61 in N-ethyl-N-hydroxyethylnitrosamine- or N-nitrosomorpholine-induced renal cell tumors in rats.
Matsumoto K; Tsuda H; Iwase T; Ito M; Nishida Y; Oyama F; Titani K; Ushijima T; Nagao M; Hirono I
Jpn J Cancer Res; 1992 Sep; 83(9):933-6. PubMed ID: 1429202
[TBL] [Abstract][Full Text] [Related]
4. Infrequent point mutations of ras oncogenes in gastric cancers.
Nanus DM; Kelsen DP; Mentle IR; Altorki N; Albino AP
Gastroenterology; 1990 Apr; 98(4):955-60. PubMed ID: 2179035
[TBL] [Abstract][Full Text] [Related]
5. Ras oncogene mutations in benign and malignant thyroid neoplasms.
Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
7. Incidence of ras oncogene activation in lung carcinomas in Hong Kong.
Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW
Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782
[TBL] [Abstract][Full Text] [Related]
8. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases.
Warnakulasuriya KA; Chang SE; Johnson NW
J Oral Pathol Med; 1992 May; 21(5):225-9. PubMed ID: 1403838
[TBL] [Abstract][Full Text] [Related]
9. Point mutations of c-ras genes in human bladder cancer and kidney cancer.
Nagata Y; Abe M; Kobayashi K; Saiki S; Kotake T; Yoshikawa K; Ueda R; Nakayama E; Shiku H
Jpn J Cancer Res; 1990 Jan; 81(1):22-7. PubMed ID: 2108944
[TBL] [Abstract][Full Text] [Related]
10. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
11. [Significance of oncogenes and growth factors in hypernephroma].
Peter S
Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800
[TBL] [Abstract][Full Text] [Related]
12. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin.
van der Schroeff JG; Evers LM; Boot AJ; Bos JL
J Invest Dermatol; 1990 Apr; 94(4):423-5. PubMed ID: 2179417
[TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ras DNA sequences in rat renal cell carcinoma.
Recio L; Lane SC; Ginsler J; Walker C
Mol Carcinog; 1991; 4(5):350-3. PubMed ID: 1910479
[TBL] [Abstract][Full Text] [Related]
15. Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.
Waldmann V; Rabes HM
J Cancer Res Clin Oncol; 1996; 122(4):207-13. PubMed ID: 8601572
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and growth factors in renal cell carcinoma.
Peter S
Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
[TBL] [Abstract][Full Text] [Related]
17. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
Akiyama T; Hamazaki S; Okada S
Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
[TBL] [Abstract][Full Text] [Related]
18. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
[TBL] [Abstract][Full Text] [Related]
19. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
20. A point mutation of c-Ki-ras gene was found in human esophageal carcinoma cell lines but not in primary esophageal carcinomas.
Shiga C; Shiga K; Sasano H; Mori S
Biochem Biophys Res Commun; 1992 Aug; 187(1):515-21. PubMed ID: 1520342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
